ArticleMolecular cancer therapeutics2024

Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel.

Ailed M Cruz-Collazo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.